Cartography Biosciences Funding: $124M Raised, Series B

Cartography Biosciences is a Biotech company based in Cambridge, MA. It has raised $124M in total funding. Latest round: Series B.

Cartography Biosciences funding overview

Cartography Biosciences is a Biotech company based in Cambridge, MA. Cartography Biosciences has raised $124M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2025. The round record for Cartography Biosciences runs through 2025; nothing later has been disclosed. Investors on record include 8VC, Andreessen Horowitz, Wing Venture Capital, Catalio Capital Management, ARTIS Ventures, Cancer Research Institute and 4 others. 10 distinct backers are named across the disclosed rounds.

Cartography Biosciences at a glance

Total raised
$124M
Latest round
Series B
Latest round date
September 2025
Industry
Biotech
Headquarters
Cambridge, MA
Notable investors
8VC, Andreessen Horowitz, Wing Venture Capital, Catalio Capital Management, ARTIS Ventures, Cancer Research Institute, Alexandria Real Estate Equities, Inc., AME Cloud Ventures

Frequently asked about Cartography Biosciences funding

How much has Cartography Biosciences raised?
Cartography Biosciences has raised $124M in total disclosed funding across the rounds on record.
Who has invested in Cartography Biosciences?
8VC, Andreessen Horowitz, Wing Venture Capital, Catalio Capital Management, ARTIS Ventures, Cancer Research Institute are named among the investors backing Cartography Biosciences.
What was the latest Cartography Biosciences funding round?
The most recent disclosed round is a Series B, announced in September 2025.
Where is Cartography Biosciences based?
Cartography Biosciences is based in Cambridge, MA.
What sector does Cartography Biosciences operate in?
Cartography Biosciences is tracked under Biotech from Cambridge, MA, with $124M in disclosed funding.
When did Cartography Biosciences last raise?
The last disclosed Cartography Biosciences round closed in September 2025 at Series B.

Round data for Cartography Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.

Cartography Biosciences founders (1)

Companies related to Cartography Biosciences (40)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades